FORT WAYNE, IN - January 15, 2026 - - Ask An Audiologist has published a new guide explaining normal hearing range Hz by age, helping readers understand how hearing changes gradually and what ...

Feb. 13 (UPI) --Regenerative medicine company Frequency Therapeutics announced Monday it will scrap development of a drug called FX-322, after testing failed to show improvement in speech perception ...

An experimental regenerative therapy that Frequency Therapeutics was developing to treat a form of hearing loss has failed to beat a placebo in a clinical trial for the second time in two years, ...

Frequency Therapeutics has raised $62 million to take its Astellas-partnered hearing loss drug into phase 2a studies. The series C round is the latest in a series of boosts for Frequency’s attempts to ...

Astellas Pharma will partner with Frequency Therapeutics to develop Frequency’s lead candidate—the Phase IIa-bound sensorineural hearing loss regenerative therapeutic FX-322—through a collaboration ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate ...

Find a Hearing Aid partner near you. Find a match Find a Hearing Aid partner near you. Hearing tests are simple and painless procedures that determine the severity and type of hearing loss you may ...